Is the therapeutic effect of clozapine associated with epileptogenic activity in deep brain nuclei?

1993 ◽  
Vol 9 (2-3) ◽  
pp. 236 ◽  
Author(s):  
D.D. Denney ◽  
J.R. Stevens
2020 ◽  
Vol 27 (12) ◽  
pp. 1734-1741
Author(s):  
Colleen H. Neal ◽  
Akshat C. Pujara ◽  
Ashok Srinivasan ◽  
Thomas L. Chenevert ◽  
Dariya Malyarenko ◽  
...  
Keyword(s):  

2018 ◽  
Vol 53 (12) ◽  
pp. 748-754 ◽  
Author(s):  
Guillaume P.O. Marie ◽  
Polona Pozeg ◽  
Reto A. Meuli ◽  
Philippe Maeder ◽  
Joachim Forget

Nature ◽  
2008 ◽  
Vol 452 (7183) ◽  
pp. E1-E1 ◽  
Author(s):  
Hugh Staunton

Brain ◽  
2020 ◽  
Vol 143 (9) ◽  
pp. 2664-2672
Author(s):  
Bhavya R Shah ◽  
Vance T Lehman ◽  
Timothy J Kaufmann ◽  
Daniel Blezek ◽  
Jeff Waugh ◽  
...  

Abstract Magnetic resonance guided high intensity focused ultrasound is a novel, non-invasive, image-guided procedure that is able to ablate intracranial tissue with submillimetre precision. It is currently FDA approved for essential tremor and tremor dominant Parkinson’s disease. The aim of this update is to review the limitations of current landmark-based targeting techniques of the ventral intermediate nucleus and demonstrate the role of emerging imaging techniques that are relevant for both magnetic resonance guided high intensity focused ultrasound and deep brain stimulation. A significant limitation of standard MRI sequences is that the ventral intermediate nucleus, dentatorubrothalamic tract, and other deep brain nuclei cannot be clearly identified. This paper provides original, annotated images demarcating the ventral intermediate nucleus, dentatorubrothalamic tract, and other deep brain nuclei on advanced MRI sequences such as fast grey matter acquisition T1 inversion recovery, quantitative susceptibility mapping, susceptibility weighted imaging, and diffusion tensor imaging tractography. Additionally, the paper reviews clinical efficacy of targeting with these novel MRI techniques when compared to current established landmark-based targeting techniques. The paper has widespread applicability to both deep brain stimulation and magnetic resonance guided high intensity focused ultrasound.


2017 ◽  
Vol 39 (1) ◽  
pp. 24-30 ◽  
Author(s):  
S. Kinner ◽  
T.B. Schubert ◽  
R.J. Bruce ◽  
S.L. Rebsamen ◽  
C.A. Diamond ◽  
...  

2020 ◽  
pp. 1-10 ◽  
Author(s):  
Cristina V. Torres ◽  
Guillermo Blasco ◽  
Marta Navas García ◽  
Elena Ezquiaga ◽  
Jesús Pastor ◽  
...  

OBJECTIVEInitial studies applying deep brain stimulation (DBS) of the posteromedial hypothalamus (PMH) to patients with pathological aggressiveness have yielded encouraging results. However, the anatomical structures involved in its therapeutic effect have not been precisely identified. The authors’ objective was to describe the long-term outcome in their 7-patient series, and the tractography analysis of the volumes of tissue activated in 2 of the responders.METHODSThis was a retrospective study of 7 subjects with pathological aggressiveness. The findings on MRI with diffusion tensor imaging (DTI) in 2 of the responders were analyzed. The authors generated volumes of tissue activated according to the parameters used, and selected those volumes as regions of interest to delineate the tracts affected by stimulation.RESULTSThe series consisted of 5 men and 2 women. Of the 7 patients, 5 significantly improved with stimulation. The PMH, ventral tegmental area, dorsal longitudinal fasciculus, and medial forebrain bundle seem to be involved in the stimulation field.CONCLUSIONSIn this series, 5 of 7 medication-resistant patients with severe aggressiveness who were treated with bilateral PMH DBS showed a significant long-lasting improvement. The PMH, ventral tegmental area, dorsal longitudinal fasciculus, and medial forebrain bundle seem to be in the stimulation field and might be responsible for the therapeutic effect of DBS.


2020 ◽  
Author(s):  
Chao Li ◽  
Xue-lian Chu ◽  
Min Tian ◽  
Feng Li ◽  
Shu-jun Xu ◽  
...  

Abstract Background: Non-motor symptoms in PD usually arise at very early stage and suffer the damage decades from diagnose. Deep brain stimulation (DBS) is considered as a highly efficient treatment option for PD’s motor function. However, the effect of DBS on NMS, especially hyposmia, has not been fully understood and there are contradictory data among different researches.Objective: The objective of this study was to evaluate the therapeutic effect of DBS on hyposmia in PD patients with a cohort study and identified whether the olfactory function scores influence the final surgery effect.Methods: A meta-analysis including six studies with 326 patients were conducted to evaluate the exact therapeutic effect of DBS on hyposmia in PD. Sub-group analyses based on sample size, gender, stimulation parameters were carried out to distinguish the difference. Sensitivity analysis was conducted to evaluate studies’ heterogeneity and stability. Potential publication bias were evaluated by Egger’s tests and the funnel plots.Results: Our study showed that DBS had clearly improved olfactory function in Parkinson patients (P < 0.0001) and the group heterogeneity as well as the publication bias advocate the convince of the result (Heterogeneity: Chi² = 6.39, df = 5 (P = 0.38); I² = 22%). Subgroup analysis also found that different groups of gender, education level or stimulation parameters have no obvious discrepancy on olfactory function improvement except age groups.Conclusion: In summary, this article summarize studies about DBS and hyposmia and offer evidences for the notion that DBS has authentic therapeutic value on the hyposmia in PD.


Sign in / Sign up

Export Citation Format

Share Document